Drug Manufacturers—General Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 11 |  LLY Eli Lilly and Company Common Stock | 1247.64 USD | -0.57% | +3.95% | +3.88% | +75.60% | 1.17 T USD | ||
| 19 |  JNJ Johnson & Johnson Common Stock | 273.08 USD | +1.03% | +1.73% | +4.01% | +52.14% | 658.10 B USD | ||
| 22 |  ABBV AbbVie Inc. Common Stock | 264.56 USD | -0.14% | +4.18% | +2.28% | +25.80% | 467.51 B USD | ||
| 33 |  MRK Merck & Company, Inc. Common Stock | 150.69 USD | -1.20% | +9.70% | +14.98% | +73.15% | 371.78 B USD | ||
| 42 |  NVS Novartis AG | 157.99 USD | -0.55% | +2.84% | +0.91% | +24.60% | 301.47 B USD | ||
| 59 |  AMGN Amgen Inc. - Common Stock | 443.79 USD | +1.02% | +5.82% | +17.23% | +51.67% | 239.93 B USD | ||
| 84 |  GILD Gilead Sciences, Inc. - Common Stock | 146.74 USD | +0.42% | +5.63% | +12.02% | +27.70% | 181.95 B USD | ||
| 102 |  PFE Pfizer, Inc. Common Stock | 27.98 USD | -0.32% | +3.06% | +13.88% | +8.16% | 159.48 B USD | ||
| 113 |  BMY Bristol-Myers Squibb Company Common Stock | 67.29 USD | +0.40% | +2.58% | +7.84% | +40.30% | 137.45 B USD | ||
| 140 |  GSK GSK plc American Depositary Shares | 51.80 USD | -1.18% | +2.01% | -0.46% | +18.13% | 111.77 B USD | ||
| 141 |  SNY Sanofi - American Depositary Shares | 45.66 USD | -0.41% | +2.81% | +4.41% | -10.63% | 111.36 B USD | ||
| 370 |  ONC BeOne Medicines Ltd - American Depositary Shares | 371.98 USD | -0.66% | +2.61% | +13.50% | +17.83% | 42.29 B USD | ||
| 442 |  BIIB Biogen Inc. - Common Stock | 218.02 USD | +0.57% | +4.24% | +7.53% | +56.84% | 32.21 B USD | ||
| 1131 |  CGON CG Oncology, Inc. - Common stock | 78.24 USD | -1.97% | +1.47% | +10.34% | +79.61% | 6.94 B USD | ||
| 1139 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 102.39 USD | -5.16% | -9.12% | +11.66% | +219.27% | 6.78 B USD | ||
| 1496 |  MANE Veradermics, Incorporated Common Stock | 98.33 USD | -4.48% | -9.16% | -10.81% | +197.97% | 4.11 B USD | ||
| 1589 |  OGN Organon & Co. Common Stock | 13.76 USD | 0.00% | +0.36% | +1.78% | +89.53% | 3.61 B USD | ||
| 1682 |  MBX MBX Biosciences, Inc. - Common Stock | 66.46 USD | +0.20% | -2.62% | +6.78% | +366.06% | 3.20 B USD | ||
| 1892 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 49.36 USD | +2.32% | +1.94% | +20.95% | +88.47% | 2.37 B USD | ||
| 1935 |  GENB Generate Biomedicines, Inc. - Common Stock | 17.71 USD | +9.86% | +12.87% | +29.84% | +18.07% | 2.27 B USD |
Haberler Drug Manufacturers—General Stocks
Roche ve Eli Lilly’nin Alzheimer testi FDA onayı aldı
Avrupa Komisyonu TNBC için Trodelvy-Keytruda kombinasyonunu onayladı
Eli Lilly kilo kaybı hapı Foundayo’yu İngiltere’de piyasaya sürdü
GSK’nın hepatit B ilacı Japonya’da onay aldı, FDA incelemesi başladı
FDA, GSK’nın Jemperli başvurusunu rektum kanseri için kabul etti
GSK’nın Hibsago ilacı Japonya’da küresel ilk onayı aldı
ATAI Beckley satın alma öncesi son raporda kazanç açıklayacak
Gainers Drug Manufacturers—General Stocks
 VBIO Valion Bio, Inc. - Common stock | 0.16 | +33.33% |
GENB Generate Biomedicines, Inc. - Common Stock | 17.71 | +9.86% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 1.16 | +7.41% |
 DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 | +6.43% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0600 | +6.38% |
 MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.80 | +5.26% |
 PTHS Pelthos Therapeutics Inc. Common Stock | 26.59 | +3.18% |
 PVLA Palvella Therapeutics, Inc. - Common Stock | 145.85 | +2.68% |
Losers Drug Manufacturers—General Stocks
 KAPA Kairos Pharma, Ltd. Common Stock | 0.24 | -17.24% |
 PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.88 | -9.18% |
 EXOZ eXoZymes Inc. - Common Stock | 6.95 | -5.83% |
 QCLS Q/C Technologies, Inc. - Common Stock | 2.43 | -5.81% |
 UPB Upstream Bio, Inc. - Common Stock | 6.59 | -5.45% |
ORKA Oruka Therapeutics, Inc. - Common Stock | 102.39 | -5.16% |
MANE Veradermics, Incorporated Common Stock | 98.33 | -4.48% |
 MDCX Medicus Pharma Ltd. - Common Stock | 0.26 | -3.70% |